Business Wire

BDA

3.5.2022 21:06:05 CEST | Business Wire | Press release

Share
BDA to Welcome Global Climate Leaders to Bermuda for Climate Summit in May

The Bermuda Business Development Agency (BDA), in partnership with the Association of Bermuda Insurers and Reinsurers (ABIR) and KBRA, is pleased to welcome climate thought leaders from around the world to Bermuda for an invite-only Bermuda Climate Summit May 23-24. The event is already at capacity, but parties interested in being added to the waitlist can email bermudaclimate@bda.bm .

The inaugural Bermuda Climate Summit will consist of an opening welcome dinner on May 23, followed by a full day of discussions on May 24, including a keynote lunch, informative panel presentations, roundtables, solutions showcase, networking opportunities, and a cocktail reception.

David Hart, BDA CEO said, “As the world’s risk capital, Bermuda is in a prime position to leverage its strengths in (re)insurance, Insurance-Linked Securities (ILS), and professional services to become the preeminent leader in climate risk finance and combat the greatest challenge of our time – climate change. Bermuda is already home to many of the world’s leading experts on weather-related catastrophes and has been working in the property catastrophe reinsurance market for decades. We are honoured to welcome global leaders to Bermuda for this extraordinary event to network, share ideas, and discuss vital solutions to the global climate crisis.”

The Hon. Walter Roban, JP, MP, Deputy Premier of Bermuda and Jim Nadler, President & CEO, KBRA will kick off proceedings by discussing Bermuda’s work in climate risk finance and how an increase in this type of financing can help mitigate against the worst effects of climate change, the benefits that innovative new technologies bring, and what a new climate finance economic pillar for Bermuda might look like.

Then John Huff, ABIR President & CEO, will moderate a panel on building resiliency in the face of climate change. Panelists include Bronwyn Claire, Senior Programme Manager, ClimateWise, Cambridge Institute for Sustainability Leadership (CISL), University of Cambridge; Ekhosuehi Iyahen, Secretary General, Insurance Development Forum; Abhisheik Dhawan, Sustainable Finance & Partnership Specialist/Corporate Lead on Climate Change, United Nations Capital Developments Fund (UNCDF); and Steven E Seitz, Director, Federal Insurance Office US Department of the Treasury.

Additional sessions will feature discussions about applied technology innovations to discuss the scale and nature of our current and anticipated climate challenges, an executive-level discussion on the growing importance of ESG and its intersection with (re)insurance and investing, and how the development of specialty financing products within the (re)insurance industry can help address climate change amid increasing consumer and regulatory pressure for climate risk management.

Guests will stay at the exclusive Rosewood Bermuda located on the shimmering waters of Bermuda’s Castle Harbour. They and their families can stay for the Bermuda Day holiday weekend to enjoy the luxury facilities and Bermuda’s many amenities including walking nature tours, twizzy tours, golf, deep-sea fishing, cave adventures, a VIP Bermuda Institute of Ocean Sciences (BIOS) tour, or a Nonsuch Island expedition. Click here to visit the BDA website for special rates and hotel information, including at the Hamilton Princess & Beach Club, conveniently located near the city of Hamilton.

The BDA thanks sponsors of Bermuda Climate Summit for their commitment to Bermuda. These include:

Partner level sponsors

  • ABIR
  • KBRA

Platinum sponsor

  • Conduit Re

Gold sponsor

  • Belco

Silver sponsor

  • Aspen Re

Lanyard sponsor

  • AXA XL

Beverage station sponsor

  • Deloitte

Bronze sponsors

  • Nephila
  • HSBC Bermuda

Supporting sponsors

  • Elbow Beach Capital
  • Hub Culture
  • KPMG

Media partner

  • Bermuda Re + ILS

Click here to learn more about the BDA.

CONNECTING BUSINESS

The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and

Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release

Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit

Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse

Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig

PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release

Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli

Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release

Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye